NCT00619463

Brief Summary

The purpose of the study is to determine the efficacy of aerobic exercise for improving cognition, mood, and fatigue after Traumatic Brain Injury (TBI) as well as examine the role of Brain Derived Neurotropic Factor (BDNF) and peripheral Vascular Endothelial Growth Factor (VEGF) as mediators of response to exercise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
154

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2007

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2007

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 11, 2008

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 21, 2008

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
Last Updated

September 24, 2013

Status Verified

September 1, 2013

Enrollment Period

5.2 years

First QC Date

February 11, 2008

Last Update Submit

September 23, 2013

Conditions

Keywords

Traumatic Brain InjuryExerciseCognitionBrain Derived Neurotrophic Factor (BDNF)peripheral vascular endothelial growth factor (VEGF)

Outcome Measures

Primary Outcomes (9)

  • Hopkins Verbal Learning Test-Revised (HVLT-R)

    Every 8 weeks for 24 weeks

  • Trail Making Tests A and B (TMT)

    Every 8 weeks for 24 weeks

  • Digit span subtests of the WAIS-III

    Every 8 weeks for 24 weeks

  • Wisconsin card sort test (WCST)

    Every 8 weeks for 24 weeks

  • Controlled Oral Word Association Test (COWAT)

    Every 8 weeks for 24 weeks

  • Stroop Word Color Test

    Every 8 weeks for 24 weeks

  • Global Fatigue Index (GFI)

    Every 8 weeks for 24 Weeks.

  • Beck Depression Inventory-II ( BDI-II)

    Every 8 weeks for 24 Weeks.

  • Blood draws for assessment of BDNF and VEGF levels

    Every 8 weeks for 24 weeks

Secondary Outcomes (7)

  • Injury characteristics and demographic variables

    At the beginning of the study. Week 1 of 24

  • BISQ - Brain Injury Screening Questionnaire

    At the beginning of the study. Week 1 of 24

  • Life 3

    Every 8 weeks for 24 Weeks

  • Transition Measures

    Every 8 weeks for 24 Weeks

  • University of Rhode Island Change Assessment (URICA)

    Every 8 weeks for 24 Weeks

  • +2 more secondary outcomes

Study Arms (2)

exercise then monitor

EXPERIMENTAL

8 weeks of aerobic exercise followed by 16 weeks of monitoring

Behavioral: Exercise

monitor than exercise

EXPERIMENTAL

8 weeks of monitoring followed by 16 weeks of aerobic exercise

Behavioral: Exercise

Interventions

ExerciseBEHAVIORAL

Eight weeks in an aerobic exercise program- 50 minutes of aerobic exercise on a treadmill - 3 days a week for 8 -16 weeks.

exercise then monitor

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be 18 to 99
  • Have experienced a TBI as a result of a blow to the head with a loss of consciousness or a period of being dazed and confused. This must be medically documented (e.g. EMS report, hospital record, physician record).
  • Be at least six-months post-injury
  • Be English-speaking since assessments and treatment sessions will be conducted by English-speaking therapists
  • Have residential telephone service since follow up assessments may be completed via phone
  • Live within 1.5 hours of NYC to be able to participate in baseline assessment and attend treatment sessions
  • Provide written informed consent for participation
  • Be willing to complete questionnaires and interviews about mood, thinking skills, fatigue, and life satisfaction
  • Being willing to comply with protocol requirements and a schedule of exercise and assessments visits
  • Being able to take part in a treadmill-based exercise program

You may not qualify if:

  • Any medical condition in which exercising may be harmful, e.g., evidence of cardiovascular compromise including: history of acute myocardial infarction, history of coronary artery disease, unstable angina, uncontrolled hypertension, orthostatic hypotension, significant aortic valve disease, uncontrolled arrhythmia, uncompensated congestive heart failure, 3rd degree AV block without a pacemaker, active pericarditis, active myocarditis, or any evidence of pulmonary, endocrine or neurologic compromise; impaired left ventricular dysfunction; or syncopal episode within the past year
  • Any medical condition requiring treatment with beta blockers or calcium channel blockers
  • Under the age of 18 years of age
  • Any clinically significant evidence of pulmonary, endocrine or neurologic (ataxia, gait disturbance, vertigo) compromise
  • Resting pulse oxymetry of less than 95% oxygen (O2) saturation, in normal air
  • Recent diagnosis of deep vein thrombosis or pulmonary embolism
  • Active systemic illness or chronic infection that is not stable
  • Active inflammatory process that is not stable
  • Clinically significant anemia
  • Clinically significant abnormal thyroid function tests
  • Pregnant females
  • Any reason that, in the investigator's opinion, makes the person unsuitable to participate
  • Unable to physically participate in an exercise program
  • Active participation in regular aerobic exercise in the six months prior to potential enrollment.
  • Active substance abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Icahn School of Medicine at Mount Sinai

New York, New York, 10029, United States

Location

MeSH Terms

Conditions

Brain Injuries, TraumaticMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Wayne Gordon, Ph.D.

    Icahn School of Medicine at Mount Sinai

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2008

First Posted

February 21, 2008

Study Start

August 1, 2007

Primary Completion

October 1, 2012

Study Completion

October 1, 2012

Last Updated

September 24, 2013

Record last verified: 2013-09

Locations